V-161
V-161 is the orally active inhibitor for Na+-V-ATPase with an IC50 of 144 nM. V-161 inhibits Enterococcus hirae and Vancomycin-resistant Enterococcus faecium (VRE) under alkaline condition with MIC of 4 µg/mL and 4 µg/mL. V-161 inhibits colonization of VRE in mouse small intestine[1].
Product Specifications
CAS Number
69570-95-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Bacterial; Na+/K+ ATPase
Related Pathways
Anti-infection; Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CC1=CC2=C(C=C1)N=C(N2)C3=CC=C(C=C3)N(C)C
Molecular Formula
C16H17N3
Molecular Weight
251.33
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Suzuki K, et al., Na+-V-ATPase inhibitor curbs VRE growth and unveils Na+ pathway structure. Nat Struct Mol Biol. 2024 Nov 21.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
E/Envelope, Dengue virus 2 (102a.a, P.pastoris, His)
E/Envelope, Dengue virus 2 (102a.a, P.pastoris, His)
E/Envelope, Dengue virus 2 (102a.a, P.pastoris, His)
